Search

everythinglearnresearchcommunity

for

Search:↓

Different medications improved various PCOS symptoms and quality of life in Pakistani women, but did not significantly help with excessive hair growth.

Finasteride helps female-pattern hair loss.

Platelet-rich plasma may improve embryo genetics in IVF.

Targeting ornithine decarboxylase can help prevent skin cancer.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Resveratrol improved menstrual regularity and reduced hair loss in women with PCOS.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

PRC2 is not essential for hair follicle stem cell maintenance or hair growth.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Bicalutamide may be a promising alternative treatment for female pattern hair loss.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Oophorectomy reduces ovarian cancer risk for women with BRCA mutations, finasteride lowers prostate cancer risk without raising death risk, and prophylactic mastectomy rates are rising.

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Activated ras can protect kidney cells from a certain substance that causes cell death.

Targeting the p300/AR axis may help treat polycystic ovary syndrome.

Increasing PBX1 reduces aging and cell death in hair follicle stem cells by boosting SIRT1 and lowering PARP1 activity.

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

Sonidegib effectively treated advanced basal cell carcinoma with mild side effects.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

Systematic end-of-trial biopsies are the most reliable way to assess outcomes.

The inhibitor affects androgen metabolism but not ovarian function.

Baricitinib successfully treated severe hair loss.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Upadacitinib improved multiple immune-related conditions in one patient.